$PLMR

Knutzen Jonathan sold $38K of PLMR

Knutzen Jonathan (Chief Risk Officer) sold 296 shares of Palomar Holdings, Inc. (PLMR) at $127.75 on 2026-08-18.

Original reporting
SEC EDGAR · Knutzen Jonathan
Published Aug 20, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PLMR
Neutral
high confidence
Mentioned
$PLMR
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLMRNeutralLow
01

Why it matters

The transaction is a routine insider sale with limited material impact.

02

Market read

Low relevance; typical insider sell with minimal market effect.

03

Timing

filed today (2026-08-20)

Relevance 3/10Novelty 4/10Timing: filed today (2026-08-20)

Background

Form 4 disclosures provide the first public record of insider transactions.

Company-level read

Ticker impact

$PLMRNeutralHigh confidence
Context

Chief Risk Officer sold 296 shares for $37,812.70 on 2026-08-18, filing a Form 4 on 2026-08-20.

Expected impact

minimal impact; price likely unchanged

Evidence & confidence

Sale size is low relative to holdings and market cap; no broader implications.

Market effects

none

none

none

Key entities

  • Palomar Holdings, Inc.

    Issuer of the shares sold.

  • Knutzen Jonathan

    Chief Risk Officer and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLMRMed

Palomar Q2 Earnings Call Highlights

Palomar (NASDAQ: PLMR) reported Q2 earnings call highlights, including crop underwriting contributions and a new AI policy administration platform (PLMR.Farm). Management guided a mid- to upper-30% full-year loss ratio, peaking in Q3. The company repurchased 368,719 shares for about $41M, authorized a $0.45 quarterly dividend, and reported $14.3M favorable prior-year reserve development.

$PLMRMedAI 8/10

Palomar Holdings, Inc. Q2 2026 Earnings Call Summary

Palomar Holdings reported record adjusted net income on diversification across earthquake, casualty, and crop. Management raised full-year 2026 adjusted net income guidance to $270 million to $280 million and expects loss ratios to trend to the mid-to-upper 30s. Palomar authorized a $0.45 quarterly dividend and cited conservative reserving, with 84% of casualty reserves as IBNR.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$PLMRMed

Palomar Holdings, Inc. (PLMR): Results of Operations and Financial Condition

Palomar Holdings, Inc. (PLMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Palomar Holdings, Inc. Reports Second Quarter 2026 Results LA JOLLA, Calif. (August 4, 2026) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $52.6 million , or $1.94 per diluted share, for the second quarter of 2026 compared to